MedPath

Methotrexate intravitreal injection to intraocular malignant lymphoma patients

Not Applicable
Recruiting
Conditions
intraocular malignant lymphoma
Registration Number
JPRN-UMIN000019667
Lead Sponsor
Yamaguchi university hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) the patient an overlap of other retina vitreous diseases fixes or doubts 2) the patient who can't have a doubtful point in a fixation check and get consent between the medical specialist 3) the patient who participated in a clinical clinical trial within 3 months of sample extraction 4) the patient who allowed a study responsibility doctor to be unsuitable

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The degree of improvement of the clinical presentation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath